Canagliflozin (CANA), a Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitor, Improves Glycemia and is Well Tolerated in Type 2 Diabetes Mellitus (T2DM) Subjects With Moderate Renal Impairment

✍ Scribed by Yale, Jean-Francois; Bakris, George; Xi, Liwen; Figueroa, Kate; Wajs, Ewa; Usiskin, Keith; Meininger, Gary

• Book ID: 122446758
• Publisher: Canadian Diabetes Association
• Year: 2012
• Tongue: English
• Weight: 79 KB
• Volume: 36
• Category: Article
• ISSN: 1499-2671
• DOI: 10.1016/j.jcjd.2012.07.344